A comparison of the effect of bcr/abl breakpoint specific phosphothiorate oligodeoxynucleotides on colony formation by bcr/abl positive and negative, CD34 enriched mononuclear cell populations

被引:14
作者
Chasty, R
Whetton, A
Lucas, G
机构
[1] MANCHESTER ROYAL INFIRM,DEPT CLIN HAEMATOL,MANCHESTER,LANCS,ENGLAND
[2] UMIST,LRF CELLULAR DEV UNIT,MANCHESTER M60 1QD,LANCS,ENGLAND
关键词
antisense oligodeoxynucleotide; CML; bcr/abl; CD34; colony inhibition;
D O I
10.1016/0145-2126(95)00124-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In chronic myeloid leukaemia, the expression by clonal cells, of a leukaemia specific bcr/abl chimeric mRNA, makes the condition suitable for the application of ''antisense'' strategies. Furthermore, the origin of the condition in a pluripotential progenitor allows enrichment of leukaemic clonogenic cells by selection for CD34 expression, together with a useful reduction in contaminating accessory cells. In a methylcellulose clonogenic assay system we incubated bcr/abl expressing (n = 9) and bcr/abl negative (n = 6), CD34 enriched progenitors with phosphothiorate oligodeoxynucleotides (PS oligomers), antisense and sense to the b3a2 and b2a2 chimeric bcr/abl junctional sequences. AII samples were cloned in the presence of both antisense, and sense PS oligomers to provide appropriate controls. For bcr/abl positive progenitors, the mean number of colonies formed was reduced by 21 (39%) (P<0.05) in the presence of the specific antisense oligomer, 11 (20%) (P<0.05) with the antisense oligomer directed to the alternative junctional breakpoint, and colony formation was not significantly altered by either sense PS oligomer. Colony formation by bcr/abl negative progenitors was not reproducibly reduced by any of the PS oligomers. These results confirm that PS oligomers can have a sequence dependent inhibitory effect on a CD34 enriched progenitor population from patients with chronic myeloid leukaemia. Copyright (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:391 / 395
页数:5
相关论文
共 11 条
  • [1] DEFABRITIIS P, 1993, BONE MARROW TRANSPL, V12, P261
  • [2] INCREASED SPECIFICITY FOR ANTISENSE OLIGODEOXYNUCLEOTIDE TARGETING OF RNA CLEAVAGE BY RNASE-H USING CHIMERIC METHYLPHOSPHONODIESTER PHOSPHODIESTER STRUCTURES
    GILES, RV
    TIDD, DM
    [J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (04) : 763 - 770
  • [3] BCR-ABL ANTISENSE PURGING IN CHRONIC MYELOID-LEUKEMIA
    KIRKLAND, MA
    OBRIEN, SG
    MCDONALD, C
    DAVIDSON, RJ
    CROSS, NCP
    GOLDMAN, JM
    [J]. LANCET, 1993, 342 (8871) : 614 - 614
  • [4] ANTISENSE OLIGOMERS IN CHRONIC MYELOID-LEUKEMIA
    MAHON, FX
    BELLOC, F
    REIFFERS, J
    [J]. LANCET, 1993, 341 (8844) : 566 - 566
  • [5] THE ROLE OF ALTERNATIVE SPLICING PATTERNS OF BCR/ABL TRANSCRIPTS IN THE GENERATION OF THE BLAST CRISIS OF CHRONIC MYELOID-LEUKEMIA
    MORGAN, GJ
    HERNANDEZ, A
    CHAN, LC
    HUGHES, T
    MARTIAT, P
    WIEDEMANN, LM
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (01) : 33 - 38
  • [6] SEGAL GM, 1993, BLOOD S1, V82
  • [7] HIGHLY EFFICIENT ELIMINATION OF PHILADELPHIA LEUKEMIC-CELLS BY EXPOSURE TO BCR/ABL ANTISENSE OLIGODEOXYNUCLEOTIDES COMBINED WITH MAFOSFAMIDE
    SKORSKI, T
    NIEBOROWSKASKORSKA, M
    BARLETTA, C
    MALAGUARNERA, L
    SZCZYLIK, C
    CHEN, ST
    LANGE, B
    CALABRETTA, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) : 194 - 202
  • [8] SKORSKI T, 1991, FOLIA HISTOCHEM CYTO, V29, P85
  • [9] SMETSERS TFCM, 1994, LEUKEMIA, V8, P129
  • [10] ANTISENSE OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS - IS THE BULLET REALLY MAGICAL
    STEIN, CA
    CHENG, YC
    [J]. SCIENCE, 1993, 261 (5124) : 1004 - 1012